Earl Bakken was eight years old when he saw the movie Frankenstein and became fascinated with the connection between electricity and life. He went on to invent the wearable external pacemaker and co-founded Medtronic in 1949. In 1967, he hired Manny Villafaña to head the company’s international sales division. In 1972, Villafaña started a competing pacemaker […]
Boston Scientific claims win over Edwards Lifesciences in German TAVR spat
Boston Scientific (NYSE:BSX) today claimed a win in its global tussle with Edwards Lifesciences (NYSE:EW) over transcatheter aortic valve replacement patents. It’s the latest development in a long-running battle being fought on multiple legal fronts over the companies’ respective TAVR patent portfolios. In March 2017, a German court issued a mixed decision in the spat, less than a week […]
Where medtech is putting its money this November
Republicans reaped nearly $3.3 million in federal political contributions from the medtech industry in the 2017-18 election cycle, compared with $1.85 million for Democrats, according to data collected by the Center for Responsive Politics, a nonprofit campaign finance watchdog group. Medtech has “historically been a little more Republican than the average industry,” said Andrew Mayersohn, committees researcher […]
Boston Scientific closes $600m Augmenix buyout
Boston Scientific (NYSE:BSX) said yesterday that it closed the $600 million acquisition of Augmenix and its SpaceOar device. The deal for Bedford, Mass.-based Augmenix, announced in September, called for $500 million in up-front cash and another $100 million pegged to sales-based milestones. “This close marks the third completed acquisition in 2018 for the company’s urology & […]
Boston Scientific touts 3-year Solyx stress urinary incontinence mesh trial data
Boston Scientific (NYSE:BSX) this week released three-year data from a study of its Solyx single incision sling system intended to treat stress urinary incontinence, touting that the trial met all primary and secondary endpoints. Boston Scientific said it presented the full results from the trial yesterday at the annual scientific symposium of the American Urogynecologic Society. The […]
Delaware court fast-tracks Channel Medsystems suit against Boston Scientific
A Delaware state court yesterday expedited a lawsuit brought by Channel Medsystems against Boston Scientific (NYSE:BSX) over a failed $275 million buyout. The lawsuit alleges that Boston Scientific spiked the deal over a former Channel employee’s alleged scheme to embezzle nearly $3 million from the women’s health company. Emeryville, Calif.-based Channel Medsystems developed Cerene, a cryogen-based endometrial ablation system […]
It’s another big year for medtech M&A
The breakneck pace of consolidation continued in 2017, significantly reducing the pool of Big 100 companies, as cash-laden companies scooped up smaller firms. The medical device industry may not be keeping pace with initial public offerings in biotech, but medtech is holding its own when comes to mergers and acquisitions, according to industry watchers. Boston […]
Medtech M&A remains hot: Here’s how
M&A in medtech show no signs of slowing in the fourth quarter of 2018, and companies looking to buy or sell have much to consider, according to patent attorney David Dykeman, a shareholder in the Boston office of the global law firm Greenberg Traurig. The number of medtech M&A deals soared by 50% in 2017 and […]
M&A chatter: Could J&J be eyeing Boston Scientific, Edwards? Did Medtronic pay too much for Mazor?
The M&A rumors in medtech are in full swing, with a Wells Fargo analyst suggesting that Johnson & Johnson (NYSE:JNJ) could be eyeing major cardiac device players Boston Scientific (NYSE:BSX) and Edwards Lifesciences (NYSE:EW) for a big-ticket buy, while a Motley Fool analyst thinks Medtronic (NYSE:MDT) may have paid too much to pick up Mazor Robotics (NSDQ:MZOR). Wells Fargo analyst […]
TCT 2018: Boston Scientific wins FDA nod for drug-eluting vascular stent
On the heels of positive study results at the 30th Transcatheter Cardiovascular Therapeutics meeting, Boston Scientific (NYSE:BSX) won FDA approval for its drug-eluting vascular stent system, Eluvia. The device, which is designed for the treatment of peripheral artery disease, uses a drug-polymer combination to deliver paclitaxel over the course of a year. Get the full story at our […]
Boston Scientific launches LithoVue Empower kidney stone retrieval device
Boston Scientific (NYSE:BSX) said today it launched its LithoVue Empower retrieval deployment device designed to be used with the LithoVue single-use digital flexible ureteroscope during ureteroscopic kidney stone retrieval procedures. The Marlborough, Mass.-based company said that the LithoVue Empower is intended to turn a two-person stone basketing procedure into a single-person procedure, allowing urologists to operate a […]
- 1
- 2
- 3
- …
- 133
- Next Page »
MassDevice Network
@MassDevice
LinkedIn